Efficacy and safety of a bridging strategy that uses intravenous platelet glycoprotein receptor inhibitors for patients undergoing surgery after coronary stent implantation: a meta-analysis

BACKGROUND: Current guidelines indicate we can consider a bridging strategy that uses intravenous, reversible glycoprotein inhibitors for patients that required surgery following recent stent implantation. However, no strong clinical evidence exists that demonstrates the efficacy and safety of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fan, Ma, Kanghua, Xiang, Rui, Han, Baoru, Chang, Jing, Zuo, Zhong, Luo, Yue, Mao, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953042/
https://www.ncbi.nlm.nih.gov/pubmed/35331138
http://dx.doi.org/10.1186/s12872-022-02563-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953042/
https://www.ncbi.nlm.nih.gov/pubmed/35331138
http://dx.doi.org/10.1186/s12872-022-02563-3

Ejemplares similares